Comparative antipsychotic claims
Executive Summary
Loxitane table entitled "Characteristics of Typical Antipsychotic Agents" is "false or misleading because it comparatively rates side effect 'potential' among antipsychotic agents without substantial evidence from head-to-head trials," FDA says. Claim that Loxitane has "effectiveness comparable to other typical antipsychotic agents" also requires substantiation, agency adds